The University of Southampton
University of Southampton Institutional Repository

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes

Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes
A cohort of MDS patients was examined for mutations affecting four splice genes (SF3B1, SRSF2, ZRSR2 and U2AF35) and evaluated in the context of clinical and molecular markers. Splice gene mutations were detected in 95 of 221 patients. These mutations were mutually exclusive and less likely to occur in patients with complex cytogenetics or TP53 mutations. SF3B1mut patients presented with lower hemoglobin levels, increased WBC and platelet counts and were more likely to have DNMT3A mutations. SRSF2mut patients clustered in RAEB-1 and RAEB-2 subtypes and exhibited pronounced thrombocytopenias. ZRSR2mut patients clustered in IPSS int-1 and int-2 risk-groups, had higher percentages of bone marrow blasts and more often displayed isolated neutropenias. SRSF2 and ZRSR2 mutations were more common in TET2mut patients. U2AF35mut patients had an increased prevalence of chromosome 20 deletions and ASXL1 mutations. Multivariate analysis revealed an inferior overall-survival (OS) and a higher AML transformation rate for the genotype ZRSR2mut/TET2wt (OS: HR 3.3; 95%CI 1.4 - 7.7; P=.006; AML transformation: HR 3.6; 95%CI 2 - 4.2; P=.026). Our results demonstrate that splice gene mutations are among the most frequent molecular aberrations in MDS, define distinct clinical phenotypes and show preferential associations with mutations targeting transcriptional regulation.

0006-4971
3211-3218
Damm, F.
a9e86b5a-6f2a-426b-8357-47ab2b6074eb
Kosmider, O.
a37be4d2-7bfd-4391-9890-936e27e848a6
Gelsi-Boyer, V.
571e36be-a5b1-4c59-9ba7-683b5e31fc9a
Renneville, A.
e1835103-9f63-4f02-bca6-aefffd08055c
Carbuccia, N.
32f2bdac-49e2-49bb-843f-32e8a7d5db8c
Hidalgo-Curtis, C.
b492ffa5-2adb-4901-973f-72e2432b0ee0
Della-Valle, V.
c4227354-1df9-4161-8b94-8584e9c09fcb
Couronne, L.
241b9e3f-42c5-4a77-a0bf-df747ba71e9a
Scourzic, L.
b90b2b2d-8801-41e0-817e-0fbf82bc48ea
Chesnais, V.
ee40c94f-2c73-4ea7-93e3-45708094ddce
Guerci-Bresler, A.
becdb1ec-d33b-404f-bd22-c00eadff618a
Slama, B.
a765dc8d-1e85-4753-8133-15ea4c3d42f9
Beyne-Rauzy, O.
4e7c002c-8a75-4fdb-9414-5c56c037844a
Schmidt-Tanguy, A.
161dd8a0-85b3-4e1b-ad4c-89c60ae145bb
Stamatoullas-Bastard, A.
1c937218-3279-4d24-8f60-b66df6de584c
Dreyfus, F.
7f5e6d73-4769-48b6-9185-8fc83db44953
Prebet, T.
9881fd25-db6e-4e71-a1f3-2ce80681a246
de Botton, S.
081f0077-aaf5-4022-847d-2233c5a3afb1
Vey, N.
6dba18d0-755d-4013-b426-8f0199584f78
Morgan, M. A.
633e16bd-907b-4072-bfdb-603178f89ab2
Cross, N. C. P.
f87650da-b908-4a34-b31b-d62c5f186fe4
Preudhomme, C.
1db28c45-3add-43f1-96b7-09d2c8442c66
Birnbaum, D.
49421576-717b-4d7c-8154-b7c670a295df
Bernard, O. A.
d6cc90c2-ae23-48a5-ba52-0144fb53de09
Fontenay, M.
a448fcda-4a42-4073-bb93-978843a65205
Damm, F.
a9e86b5a-6f2a-426b-8357-47ab2b6074eb
Kosmider, O.
a37be4d2-7bfd-4391-9890-936e27e848a6
Gelsi-Boyer, V.
571e36be-a5b1-4c59-9ba7-683b5e31fc9a
Renneville, A.
e1835103-9f63-4f02-bca6-aefffd08055c
Carbuccia, N.
32f2bdac-49e2-49bb-843f-32e8a7d5db8c
Hidalgo-Curtis, C.
b492ffa5-2adb-4901-973f-72e2432b0ee0
Della-Valle, V.
c4227354-1df9-4161-8b94-8584e9c09fcb
Couronne, L.
241b9e3f-42c5-4a77-a0bf-df747ba71e9a
Scourzic, L.
b90b2b2d-8801-41e0-817e-0fbf82bc48ea
Chesnais, V.
ee40c94f-2c73-4ea7-93e3-45708094ddce
Guerci-Bresler, A.
becdb1ec-d33b-404f-bd22-c00eadff618a
Slama, B.
a765dc8d-1e85-4753-8133-15ea4c3d42f9
Beyne-Rauzy, O.
4e7c002c-8a75-4fdb-9414-5c56c037844a
Schmidt-Tanguy, A.
161dd8a0-85b3-4e1b-ad4c-89c60ae145bb
Stamatoullas-Bastard, A.
1c937218-3279-4d24-8f60-b66df6de584c
Dreyfus, F.
7f5e6d73-4769-48b6-9185-8fc83db44953
Prebet, T.
9881fd25-db6e-4e71-a1f3-2ce80681a246
de Botton, S.
081f0077-aaf5-4022-847d-2233c5a3afb1
Vey, N.
6dba18d0-755d-4013-b426-8f0199584f78
Morgan, M. A.
633e16bd-907b-4072-bfdb-603178f89ab2
Cross, N. C. P.
f87650da-b908-4a34-b31b-d62c5f186fe4
Preudhomme, C.
1db28c45-3add-43f1-96b7-09d2c8442c66
Birnbaum, D.
49421576-717b-4d7c-8154-b7c670a295df
Bernard, O. A.
d6cc90c2-ae23-48a5-ba52-0144fb53de09
Fontenay, M.
a448fcda-4a42-4073-bb93-978843a65205

Damm, F., Kosmider, O., Gelsi-Boyer, V., Renneville, A., Carbuccia, N., Hidalgo-Curtis, C., Della-Valle, V., Couronne, L., Scourzic, L., Chesnais, V., Guerci-Bresler, A., Slama, B., Beyne-Rauzy, O., Schmidt-Tanguy, A., Stamatoullas-Bastard, A., Dreyfus, F., Prebet, T., de Botton, S., Vey, N., Morgan, M. A., Cross, N. C. P., Preudhomme, C., Birnbaum, D., Bernard, O. A. and Fontenay, M. (2012) Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. Blood, 119 (14), 3211-3218. (doi:10.1182/blood-2011-12-400994).

Record type: Article

Abstract

A cohort of MDS patients was examined for mutations affecting four splice genes (SF3B1, SRSF2, ZRSR2 and U2AF35) and evaluated in the context of clinical and molecular markers. Splice gene mutations were detected in 95 of 221 patients. These mutations were mutually exclusive and less likely to occur in patients with complex cytogenetics or TP53 mutations. SF3B1mut patients presented with lower hemoglobin levels, increased WBC and platelet counts and were more likely to have DNMT3A mutations. SRSF2mut patients clustered in RAEB-1 and RAEB-2 subtypes and exhibited pronounced thrombocytopenias. ZRSR2mut patients clustered in IPSS int-1 and int-2 risk-groups, had higher percentages of bone marrow blasts and more often displayed isolated neutropenias. SRSF2 and ZRSR2 mutations were more common in TET2mut patients. U2AF35mut patients had an increased prevalence of chromosome 20 deletions and ASXL1 mutations. Multivariate analysis revealed an inferior overall-survival (OS) and a higher AML transformation rate for the genotype ZRSR2mut/TET2wt (OS: HR 3.3; 95%CI 1.4 - 7.7; P=.006; AML transformation: HR 3.6; 95%CI 2 - 4.2; P=.026). Our results demonstrate that splice gene mutations are among the most frequent molecular aberrations in MDS, define distinct clinical phenotypes and show preferential associations with mutations targeting transcriptional regulation.

This record has no associated files available for download.

More information

Accepted/In Press date: 17 February 2012
Published date: 5 April 2012
Organisations: Human Development & Health

Identifiers

Local EPrints ID: 334320
URI: http://eprints.soton.ac.uk/id/eprint/334320
ISSN: 0006-4971
PURE UUID: 64d03981-5b70-45a6-b49b-a577288a3f9f
ORCID for N. C. P. Cross: ORCID iD orcid.org/0000-0001-5481-2555

Catalogue record

Date deposited: 06 Mar 2012 17:13
Last modified: 15 Mar 2024 03:11

Export record

Altmetrics

Contributors

Author: F. Damm
Author: O. Kosmider
Author: V. Gelsi-Boyer
Author: A. Renneville
Author: N. Carbuccia
Author: C. Hidalgo-Curtis
Author: V. Della-Valle
Author: L. Couronne
Author: L. Scourzic
Author: V. Chesnais
Author: A. Guerci-Bresler
Author: B. Slama
Author: O. Beyne-Rauzy
Author: A. Schmidt-Tanguy
Author: A. Stamatoullas-Bastard
Author: F. Dreyfus
Author: T. Prebet
Author: S. de Botton
Author: N. Vey
Author: M. A. Morgan
Author: N. C. P. Cross ORCID iD
Author: C. Preudhomme
Author: D. Birnbaum
Author: O. A. Bernard
Author: M. Fontenay

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×